These presentations by Laurence Hirsch, MD are based on the 2009 updated consensus algorithm for the treatment of type 2 diabetes, developed by the American Diabetes association and the European Association for the Study of Diabetes.
The presentations describe the rationale for rapid, continuously adjusted treatment of type 2 diabetes- this is called "treat to target."
The newest oral and injected therapies are discussed, along with a useful way to classify patients according to their A1c and other glycemic measures.